Contact Supplier

Contact Supplier

To get in touch with MEGGLE Excipients, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    MEGGLE Captopril Case Study: How excipient choice can combat tablet deformation

    white-paperMEGGLE Excipients
    April 17th 2024

    Pharmaceutical lactose specialist MEGGLE has released a technical Case Study on masking the effects of API-related elastic deformation in tableting.

    The article documents findings from a technical study using the antihypertensive Captopril as a research sample for a drug with fundamentally high elastic deformation properties that can affect compression and consequent tablet robustness.

    This study highlights the tableting obstacles encountered in conventional Captopril formulations and shows how the correct choice of lactose-based technological excipients can promote compression improvement, making scale-up more effective and robust. The study also identifies potential enhancements to drug effectiveness.

    Click below to download full study.


    Experts in Excipients - The whole world of Lactose


    Contact MEGGLE Excipients

    Simply fill out the form below to contact MEGGLE Excipients now.

    Send MEGGLE Excipients a Message